1. Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer
    Sumita Trivedi et al, 2016, Current Opinion in Otolaryngology & Head and Neck Surgery CrossRef
  2. Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment
    Corinne Levingston et al, 2017, Cancers CrossRef
  3. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis
    Yi-hui Wen et al, 2019, Cancer Immunology, Immunotherapy CrossRef
  4. Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck
    Marzieh Norouzian et al, 2022, BMC Immunology CrossRef
  5. Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage
    Fanqin Wei et al, 2023, Oral Oncology CrossRef
  6. Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
    Panagiota Economopoulou et al, 2020, Cancers CrossRef
  7. Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis
    Juan P. Rodrigo et al, 2021, Biomedicines CrossRef
  8. IL-35 expression is increased in laryngeal squamous cell carcinoma and in the peripheral blood of patients
    Wei Wu et al, 2017, Oncology Letters CrossRef
  9. T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma
    Daniele Maggioni et al, 2017, OncoImmunology CrossRef
  10. HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation
    Marcell Costa de Medeiros et al, 2017, Oncotarget CrossRef
  11. IL-21 Is an Accomplice of PD-L1 in the Induction of PD-1-Dependent Treg Generation in Head and Neck Cancer
    Yi Zhao et al, 2021, Frontiers in Oncology CrossRef
  12. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127
    Fang Zhou et al, 2017, Immunologic Research CrossRef
  13. A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma
    Wei Sun et al, 2017, British Journal of Cancer CrossRef
  14. Prognostic Impact of Tumor Immune Microenvironment and Its Predictive Role in Salivary Gland Cancer
    Maria Vittoria Veneroni et al, 2023, Head and Neck Pathology CrossRef
  15. Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD‐1 antibodies
    Corinne A. Levingston et al, 2017, International Journal of Cancer CrossRef
  16. Treg: A Promising Immunotherapeutic Target in Oral Diseases
    Yujing Zhang et al, 2021, Frontiers in Immunology CrossRef
  17. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma
    Wei Sun et al, 2016, Oncotarget CrossRef
  18. Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
    Imelda Seminerio et al, 2019, Cancers CrossRef
  19. Treatment to sustain a Th17‐type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer
    M. Rita I. Young et al, 2016, International Journal of Cancer CrossRef
  20. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
    Jian-Feng Liu et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
  21. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination
    Fan-Qin Wei et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
  22. Th2 Cells Are Associated with Tumor Recurrence Following Radiation
    Mohamed K. Abdelhakiem et al, 2024, Cancers CrossRef